TABLE 1.
Clinical parameters | Cases | Expression level | P value | |
---|---|---|---|---|
MiR‐3677‐3phigh (n = 70) | MiR‐3677‐3plow (n = 67) | |||
Age (years) | ||||
<65 y | 72 | 35 | 37 | .608 |
≥65 y | 65 | 35 | 30 | |
Gender | ||||
Male | 114 | 62 | 52 | .110 |
Female | 23 | 8 | 15 | |
Tumour size (cm) | ||||
<5 cm | 50 | 27 | 23 | .723 |
≥5 cm | 87 | 43 | 44 | |
Tumour number | ||||
Solitary | 80 | 28 | 52 | .001 |
Multiple | 57 | 42 | 15 | |
Edmondson | ||||
I + II | 89 | 32 | 57 | .003 |
III + IV | 48 | 38 | 10 | |
TNM stage | ||||
I + II | 87 | 31 | 56 | .011 |
III + IV | 50 | 39 | 11 | |
Venous invasion | ||||
Present | 73 | 29 | 44 | .016 |
Absent | 64 | 41 | 23 | |
AFP | ||||
<400 ng/mL | 61 | 35 | 26 | .229 |
≥400 ng/mL | 76 | 35 | 41 | |
HBVsAg | ||||
Positive | 114 | 56 | 58 | .364 |
Negative | 23 | 14 | 9 |
Bold font statistically significant.
Abbreviations: AFP, alpha‐feto protein; HCC, hepatocellular carcinoma; TNM, tumour‐node‐metastasis.